These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31859200)

  • 41. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink.
    Caspard H; Steffey A; Mallory RM; Ambrose CS
    BMJ Open; 2018 Dec; 8(12):e023118. PubMed ID: 30530581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME; Piedra PA; Longini IM; Gaglani MJ; Schmotzer B; Fewlass C; Herschler GB; Glezen WP
    Vaccine; 2007 May; 25(20):4038-45. PubMed ID: 17395338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between vaccine adjuvant effect and pre-seasonal immunity. Systematic review and meta-analysis of randomised immunogenicity trials comparing squalene-adjuvanted and aqueous inactivated influenza vaccines.
    Beyer WEP; Palache AM; Reperant LA; Boulfich M; Osterhaus ADME
    Vaccine; 2020 Feb; 38(7):1614-1622. PubMed ID: 31879122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias.
    Hottes TS; Skowronski DM; Hiebert B; Janjua NZ; Roos LL; Van Caeseele P; Law BJ; De Serres G
    PLoS One; 2011; 6(7):e22618. PubMed ID: 21818350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review and meta-analysis of the effectiveness of LAIV4 and IIV in children aged 6 months to 17 years during the 2016-2017 season.
    Mallory RM; Bandell A; Ambrose CS; Yu J
    Vaccine; 2020 Apr; 38(18):3405-3410. PubMed ID: 31917037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
    Shinjoh M; Sugaya N; Furuichi M; Araki E; Maeda N; Isshiki K; Ohnishi T; Nakamura S; Yamada G; Narabayashi A; Nishida M; Taguchi N; Nakata Y; Yoshida M; Tsunematsu K; Shibata M; Munenaga T; Hirano Y; Ookawara I; Sekiguchi S; Kobayashi Y; Yamaguchi Y; Yoshida N; Mitamura K; Takahashi T;
    Vaccine; 2019 Jul; 37(30):4047-4054. PubMed ID: 31186191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.
    Bellino S; Bella A; Puzelli S; Di Martino A; Facchini M; Punzo O; Pezzotti P; Castrucci MR; The InfluNet Study Group
    Expert Rev Vaccines; 2019 Nov; 18(11):1201-1209. PubMed ID: 31674847
    [No Abstract]   [Full Text] [Related]  

  • 55. Influenza in Poland in 2013 and 2013/2014 epidemic season.
    Kondratiuk K; Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Cielebąk E; Brydak LB
    Przegl Epidemiol; 2016; 70(3):407-419. PubMed ID: 27883286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza epidemiology and influenza vaccine effectiveness during the 2016-2017 season in the Global Influenza Hospital Surveillance Network (GIHSN).
    Baselga-Moreno V; Trushakova S; McNeil S; Sominina A; Nunes MC; Draganescu A; Unal S; Koul P; Kyncl J; Zhang T; Kuatbayeva A; Ben-Salah A; Burtseva E; Puig-Barberà J; Díez-Domingo J;
    BMC Public Health; 2019 May; 19(1):487. PubMed ID: 31046725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.
    McLean HQ; Peterson SH; King JP; Meece JK; Belongia EA
    Influenza Other Respir Viruses; 2017 May; 11(3):220-229. PubMed ID: 27885805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do parents prefer inactivated or live attenuated influenza vaccine for their children?
    Santibanez TA; Kahn KE; Bridges CB
    Vaccine; 2018 Nov; 36(48):7300-7305. PubMed ID: 30340880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
    Shang M; Chung JR; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Fry AM; Flannery B
    Vaccine; 2018 Dec; 36(52):8047-8053. PubMed ID: 30420119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.